Search

Author/Creator Nowak, Anna

1. 293 Resultsof the first-in-human clinical trial with personalized multi-target adoptive cell therapy (ACTolog IMA101). (9th November 2020)

Authors:
Tsimberidou, Apostolia; Guenther, Kerstin; Alpert, Amir; Andersson, Borje; Coughlin, Zoe; Fritsche, Jens; Hilf, Norbert; Hwu, Patrick; Kalra, Mamta; Kuttruff-Coqui, Sabrina; Maurer, Dominik; Mendrzyk, Regina; Mohamed, Ali; Norris, Becky; Nowak, Anna; Ort, Rita; Reinhardt, Carsten; Richter, Fabian...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A179
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ACTR-11. SECOND INTERIM AND 1ST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CODELETION. (11th November 2019)

Authors:
van den Bent, Martin; Erridge, Sara; Vogelbaum, Michael; Nowak, Anna; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Baurain, Jean-Francais; Mason, Warren; Wheeler, Helen; Weller, Michael; aldape, ken; Wesseling, Pieter; Kros, Johan; Tesileanu, Mircea; Golfinopoulos, Vassilis; Gorlia...
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. CTNI-14. A 3-ARM, PHASE IIA TRIAL OF SAFETY & EFFICACY OF OLINVACIMAB, A MONOCLONAL ANTIBODY TO VEGFR2 IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME WITH IMAGING AND PK/PD ASSESSMENTS: FINAL REPORT. (9th November 2020)

Authors:
Cher, Lawrence; Nowak, Anna; Iatropoulos, George; Bowyer, Samantha; Gan, Hui; Long, Anne Poh; Bynevelt, Michael; Jackson, Graeme; Lee, Seon Young; Lee, Weon Sup; Yoo, Jin-San
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA. (9th November 2020)

Authors:
Tesileanu, C Mircea S; French, Pim; Erridge, Sarah; Vogelbaum, Michael; Nowak, Anna; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Baurain, Jean; Mason, Warren; Wheeler, Helen; Weller, Michael; Aldape, Kenneth; Wesseling, Pieter; Kros, Johan M; Golfinopoulos, Vassilis; Gorlia, Thier...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Effect of 2′-O-[2-[2-(N, N-dimethylamino)ethoxy]ethyl] modification on activity of gapmer antisense oligonucleotides containing 2′, 4′-constrained 2′-O-ethyl nucleic acid. Issue 8 (15th April 2015)

Authors:
Pandey, Sanjay K.; Nowak, Anna; Perkins, Jake; Ferng, Annie; Prakash, Thazha P.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 25:Issue 8(2015)
Page Start:
1688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗